DNA Stock Analysis: Buy, Sell, or Hold?
DNA - Ginkgo Bioworks Holdings, Inc.
$10.40
0.12 (1.17%)
▲
5d:
+8.67%
30d:
+11.47%
90d:
+53.17%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When DNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: DNA is 7.3% above its trading range ($9.69). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: DNA is 7.3% above its trading range ($9.69). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: DNA is currently trading at $10.40, which is considered extended relative to its 30-day fair value range of $8.23 to $9.69.
Technical Outlook: Technically, DNA is in a strong uptrend. Immediate support is located at $8.66, while resistance sits at $11.14.
Market Sentiment: DNA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $8.50. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DNA is in a strong uptrend. Immediate support is located at $8.66, while resistance sits at $11.14.
Market Sentiment: DNA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $8.50. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$8.23 -
$9.69
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
47.4%
Protect Your Profits
Holding DNA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+7.3% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 18.3% above Wall St target ($8.50)
Trading Range Analysis
30-Day Trading Range
$8.23 -
$9.69
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$8.66
Resistance Level
$11.14
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.24
Wall Street Target
$8.50
(-18.3%)
Revenue Growth (YoY)
-49.1%
Profit Margin
-201.0%
Share & Embed Analysis
Last updated: July 05, 2026 5:39 AM ET
Data refreshes hourly during market hours. Next update: 6:39 AM
Data refreshes hourly during market hours. Next update: 6:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
Steven P Coen
SELL
324 shares
2026-04-17
Steven P Coen
SELL
33171 shares
2026-04-13
Barry Canton
SELL
124727 shares
2026-04-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$106 | 64 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 54 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 45 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$189 | 62 BUY |
Advanced DNA Option Strategies
Professional options setups generated by AI based on today's DNA price and gamma walls.
